org placeholder image

Pallavi Kolte

Associate Director Program Management at CRISPR Therapeutics

  • LinkedIn

Email Email: p****@selectabio.com

phone noPhone Number: (***)-***-****

map
CRISPR THERAPEUTICS

CRISPR THERAPEUTICS

  • description Description
    CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is...

    Read More

  • Employees count Employees 201-500
  • Revenue Revenue 100 Million to 250 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

CRISPR Therapeutics Org Chart and Mapping

Employees

Geoff Small

Senior Research Associate

Jesse Hernandez

Manager Quality Operations

Paul Sullivan

Senior Director of Market Access

Shefali Vaidya

Senior Research Associate

Daniel Pascual

Principal Research Associate

Nicolette Lee

Senior Bioinformatics Engineer

Frequently Asked Questions Regarding Pallavi Kolte

Answer: Pallavi Kolte works for CRISPR Therapeutics as Associate Director Program Management

Answer: Pallavi Kolte’s role in CRISPR Therapeutics is Associate Director Program Management

Answer: Pallavi Kolte's email address is p***@gmail.com

Answer: Pallavi Kolte's business email address is p****@selectabio.com

Answer: Pallavi Kolte’s direct phone number is (***)-***-****

Answer: Pallavi Kolte works in the industry of: Biotechnology

Answer: Pallavi Kolte works CRISPR Therapeutics located at 828 Winter St, Boston, Massachusetts, 02451, United States

Answer: CRISPR Therapeutics's Associate Director Program Management is Pallavi Kolte

Answer: Pallavi Kolte contact details:

  • Phone number  :  (***)-***-****
  • Email  :  p****@selectabio.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access